Previous close | 6.12 |
Open | 6.04 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 5.74 - 6.14 |
52-week range | 3.60 - 10.32 |
Volume | |
Avg. volume | 41,703 |
Market cap | 217.057M |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.53 |
Earnings date | 22 Aug 2024 - 26 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 12.53 |
LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Healthcare Conference, which is being held June 5-6, 2024, in New York City. Presentation details: Date:Wednesday, June 5thTime:7:30 AM ET Webcast:https://wsw.com/webcast/jeff302/edap/1814176 The live and archived webcas
Strong Q1 2024 U.S. Focal One® HIFU procedure growth of +92% year-over-year Q1 2024 HIFU revenue of EUR 5.8 million ($6.3 million USD), an increase of 10.2% over Q1 2023Q1 2024 total revenue of EUR 14.9 million ($16.1 million USD) increased 0.8% over Q1 2023Company to host conference call and webcast today, May 16th, at 8:30 a.m. EDT LYON, France, May 16, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today unaudited financial results for the fir
Key Insights Significant control over EDAP TMS by individual investors implies that the general public has more power...